Global Veterinary Oncology Market Expected to Hit $0.7 Billion by 2030 at 11.3% CAGR

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Autoimmune Hemolytic Anemia Treatment Market By The End Of 2030?

The veterinary oncology market has witnessed rapid expansion in recent years. Its size is projected to increase from $0.45 billion in 2025 to $0.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.0%. This historical growth can be linked to several factors, including a higher incidence of cancer among companion animals, increasing recognition of veterinary oncology provisions, technological progress in surgical and radiology equipment, the expansion of veterinary hospitals and specialized clinics, and the embrace of traditional chemotherapy treatments.

The veterinary oncology market size is set to experience substantial growth in the forthcoming years. It is forecast to grow to $0.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. This expansion during the projection period is primarily due to a rising demand for customized and specific treatments, increased adoption of advanced radiology and imaging, a surge in the use of immunotherapy and supportive care, the evolution of less invasive surgical techniques, and the integration of combination chemotherapy with targeted therapy protocols. Significant patterns expected in this forecast period include the broadening of targeted and personalized veterinary cancer therapies, an increase in minimally invasive surgical methods, greater uptake of advanced radiology and imaging technologies, the development of new combination chemotherapy protocols, and the incorporation of immunotherapy and supportive care into treatment plans.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

What Primary Drivers Are Shaping The Development Of The Autoimmune Hemolytic Anemia Treatment Market?

The increasing incidence of cancer in companion animals is anticipated to drive the veterinary oncology market forward. Cancer is a condition where certain cells in the body grow uncontrollably and spread to other areas. In pets, cancer is recognized by the physical manifestations of a tumor, such as swelling. Veterinary oncology specializes in the diagnosis and treatment of cancer in animals, with the goal of reducing metastasis and the spread of the disease. Consequently, a rise in pet cancer cases will boost the demand for veterinary oncology. For instance, The Cancer Letter, a US-based publication covering cancer research, reported that an estimated 6 million pet dogs would be diagnosed with cancer in the United States in 2024. Furthermore, according to the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, in November 2023, it was estimated that 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer during their lifetime. Therefore, the growing prevalence of cancer in pets is a key driver for the veterinary oncology market.

Which Segment Classifications Shape The Autoimmune Hemolytic Anemia Treatment Market?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

How Are Trends Impacting The Veterinary Oncology Market?

Leading companies in the veterinary oncology market are focusing on the development of neoantigens, which are distinct tumor-specific antigens that stem from mutations in cancer cells. These are unique protein fragments that emerge from tumor-specific mutations within cancer cells. In contrast to normal antigens found in healthy tissues, neoantigens are produced as a direct result of genetic alterations (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company, launched a cancer vaccine trial for dogs. Neoantigens are currently being investigated for their role in developing cancer vaccines and other immunotherapies, with the aim of specifically amplifying the immune response against cancer cells while preserving normal cells.

Which Companies Are Expanding Their Footprint In The Autoimmune Hemolytic Anemia Treatment Market?

Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc.

Read the full veterinary oncology market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

How Does The Autoimmune Hemolytic Anemia Treatment Market Perform Across Major Global Regions?

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autoimmune Hemolytic Anemia Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9533&type=smp

Browse Through More Reports Similar to the Global Veterinary Oncology Market 2026, By The Business Research Company

Wheat Protein Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wheat-protein-global-market-report

Clinical Nutritions Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-nutritions-global-market-report

Medical Foods Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-foods-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795